nach oben

Neurological Sciences

Erschienen in:

16.07.2020 | Original Article

Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life

verfasst von: Zahra Salehi, Masoud Arabfard, Omid Sadatpour, Mina Ohadi

Erschienen in: Neurological Sciences | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Aim

The aim of this study was to identify the minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life.

Methods

We searched the Online Mendelian Inheritance in Man (OMIM) database to extract the validated human genes annotated (until March 2020) for five major disorders of pathophysiological overlap and sequential chronological occurrence in human, including multiple sclerosis, type 2 diabetes mellitus, Alzheimer’s disease, vascular dementia, and Lewy body dementia. Gene co-expression and physical interaction networks were subsequently constructed for the overlapping genes across the selected disorders.

Results

Remarkably, each of the gene co-expression and physical interaction networks consisted of single clusters (P = 0.0005 and P = 1 × 10⁻¹⁶, respectively). APP was the major hub in the integrated and tissue-specific co-expression networks, whereas insulin was the major hub in the physical interaction network. Several other hubs were identified across the identified networks, including TNF, VEGFA, GAPDH, and NOTCH1.

Conclusion

We propose the minimal co-expression and physical interaction networks and their single clustering in the development of cognition impairment in human mid and late life. This is a pilot study, warranting identification of more risk genes, using additional validated databases in the future.

Nur mit Berechtigung zugänglich

Van Dyken P, Lacoste B (2018) Impact of metabolic syndrome on neuroinflammation and the blood–brain barrier. Front Neurosci 12:930PubMedPubMedCentral

de Mello NP, Orellana AM, Mazucanti CH, de Morais LG, Scavone C, Kawamoto EM (2019) Insulin and autophagy in neurodegeneration. Front Neurosci 13:491. https://doi.org/10.3389/fnins.2019.00491CrossRefPubMedPubMedCentral

Karvani M, Simos P, Stavrakaki S, Kapoukranidou D (2019) Neurocognitive impairment in type 2 diabetes mellitus. Hormones:1–12

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Author correction: multiple sclerosis. Nat Rev Dis Primers 4(1):49. https://doi.org/10.1038/s41572-018-0050-3CrossRefPubMed

Branco M, Ruano L, Portaccio E, Goretti B, Niccolai C, Patti F, Chisari C, Gallo P, Grossi P, Ghezzi A (2019) Aging with multiple sclerosis: prevalence and profile of cognitive impairment. Neurol Sci 40(8):1651–1657PubMed

Amato MP, Goretti B, Brescia Morra V, Gallo P, Zaffaroni M, Onofrj M, Cocco E, Borriello G, Zipoli V, Trojano M.Neurol Sci. 2020 May 1. https://doi.org/10.1007/s10072-020-04320-w

Hou W-H, Li C-Y, Chang H-H, Sun Y, Tsai C-C (2017) A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus. J Epidemiol 27(5):235–241PubMedPubMedCentral

Hussein WI, Reddy SS (2006) Prevalence of diabetes in patients with multiple sclerosis. Diabetes Care 29(8):1984–1985PubMed

Marrie RA (2017) Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol 13(6):375–382PubMed

10.

negrotto L, Farez MF, Correale J (2016) Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol 73(5):520–528PubMed

11.

Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, Corella D, Salas-Salvadó J, Cuenca-Royo A, Vioque J, Romaguera D, Martínez JA, Wärnberg J (2018) Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep 8(1):1–9

12.

Li W, Lin S, Li G, Xiao S (2019) Prevalence, influence factors and cognitive characteristics of mild cognitive impairment in type 2 diabetes mellitus. Front Aging Neurosci 11:180PubMedPubMedCentral

13.

Albai O, Frandes M, Timar R, Roman D, Timar B (2019) Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment. Neuropsychiatr Dis Treat 15:167–175PubMedPubMedCentral

14.

Arvanitakis Z, Shah RC, Bennett DA (2019) Diagnosis and management of dementia. Jama 322(16):1589–1599PubMedPubMedCentral

15.

Karantzoulis S, Galvin JE, Braak S, Mckhann MK, Jack S, Hodges B (2011) Distinguishing Alzheimer’s disease from other major forms of dementia. Expert Rev Neurother 11(11):1579–1591PubMedPubMedCentral

16.

Cunningham EL, McGuinness B, Herron B, Passmore AP (2015) Dementia. Ulster Med J 84(2):79–87PubMedPubMedCentral

17.

Lin Y-F, Smith AV, Aspelund T, Betensky RA, Smoller JW, Gudnason V, Launer LJ, Blacker D (2019) Genetic overlap between vascular pathologies and Alzheimer’s dementia and potential causal mechanisms. Alzheimers Dement 15(1):65–75. https://doi.org/10.1016/j.jalz.2018.08.002CrossRefPubMed

18.

Rotermund C, Machetanz G, Fitzgerald JC (2018) The therapeutic potential of metformin in neurodegenerative diseases. Front Endocrinol 9:400

19.

Shi Q, Liu S, Fonseca VA, Thethi TK, Shi L (2019) Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus. BMJ Open 9(7):e024954PubMedPubMedCentral

20.

Campbell JM, Stephenson MD, De Courten B, Chapman I, Bellman SM, Aromataris E (2018) Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis. J Alzheimers Dis 65(4):1225–1236PubMedPubMedCentral

21.

Caberlotto L, Nguyen T-P, Lauria M, Priami C, Rimondini R, Maioli S, Cedazo-Minguez A, Sita G, Morroni F, Corsi M (2019) Cross-disease analysis of Alzheimer’s disease and type-2 diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases. Sci Rep 9(1):1–13

22.

Lassmann H, van Horssen J (2011) The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585(23):3715–3723PubMed

23.

McKusick VA (2007) Mendelian Inheritance in Man and its online version, OMIM. Am J Hum Genet 80(4):588–604PubMed

24.

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork PJN (2018) STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607–D613PubMedCentral

25.

Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CTJN (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38(suppl_2):W214–W220PubMedPubMedCentral

26.

Alanis-Lobato G, Andrade-Navarro MA, Schaefer MH (2016) HIPPIE v2. 0: enhancing meaningfulness and reliability of protein–protein interaction networks. Nucleic Acids Res gkw985

27.

Doncheva NT, Morris JH, Gorodkin J, Jensen LJ (2018) Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res 18(2):623–632PubMedPubMedCentral

28.

Ikonomovic MD, Mi Z, Abrahamson EEJ (2017) Disordered APP metabolism and neurovasculature in trauma and aging: combined risks for chronic neurodegenerative disorders. Ageing Res Rev 34:51–63PubMed

29.

Pietroboni AM, Scarioni M, Carandini T, Basilico P, Cadioli M, Giulietti G, Arighi A, Caprioli M, Serra L, Sina C (2018) CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease. J Neurol Neurosurg Psychiatry 89(4):352–357PubMed

30.

Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J (1995) Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 15(2):141–151PubMed

31.

An YA, Crewe C, Asterholm IW, Sun K, Chen S, Zhang F, Shao M, Funcke J-B, Zhang Z, Straub L (2019) Dysregulation of amyloid precursor protein impairs adipose tissue mitochondrial function and promotes obesity. Nat Metab 1(12):1243–1257PubMedPubMedCentral

32.

Hancock ML, Meyer RC, Mistry M, Khetani RS, Wagschal A, Shin T, Sui SJH, Näär AM, Flanagan JG (2019) Insulin receptor associates with promoters genome-wide and regulates gene expression. Cell 177(3):722–736.e722PubMedPubMedCentral

33.

Galle SA, Van Der Spek A, Drent ML, Brugts MP, Scherder EJ, Janssen JA, Ikram MA, Van Duijn CM (2019) Revisiting the role of insulin-like growth factor-I receptor stimulating activity and the apolipoprotein E in Alzheimer’s disease. Front Aging Neurosci 11:20PubMedPubMedCentral

34.

Soto M, Cai W, Konishi M, Kahn CR (2019) Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. Proc Natl Acad Sci 116(13):6379–6384PubMed

35.

Lainampetch J, Panprathip P, Phosat C, Chumpathat N, Prangthip P, Soonthornworasiri N, Puduang S, Wechjakwen N, Kwanbunjan K (2019) Association of tumor necrosis factor alpha, interleukin 6, and C-reactive protein with the risk of developing type 2 diabetes: a retrospective cohort study of rural Thais. J Diabetes Res 2019:1–9

36.

Subedi L, Lee SE, Madiha S, Gaire BP, Jin M, Yumnam S, Kim SY (2020) Phytochemicals against TNFα-mediated neuroinflammatory diseases. Int J Mol Sci 21(3):764PubMedCentral

37.

Hu WT, Howell JC, Ozturk T, Gangishetti U, Kollhoff AL, Hatcher-Martin JM, Anderson AM, Tyor WR (2019) CSF cytokines in aging, multiple sclerosis, and dementia. Front Immunol 10

38.

Griñán-Ferré C, Marsal-García L, Bellver-Sanchis A, Kondengaden SM, Turga RC, Vázquez S, Pallàs M (2019) Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-amyloid plaques in an early-onset Alzheimer’s disease mouse model. Aging (Albany NY) 11(23):11591–11608

39.

Zuliani G, Ranzini M, Guerra G, Rossi L, Munari M, Zurlo A, Volpato S, Atti A, Ble A, Fellin R (2007) Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia. J Psychiatr Res 41(8):686–693PubMed

40.

King E, Thomas A (2017) Systemic inflammation in Lewy body diseases. Alzheimer Dis Assoc Disord 31(4):346–356PubMed

41.

Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S (2012) TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation 9(1):23PubMedPubMedCentral

42.

Moore AM, Mahoney E, Dumitrescu L, De Jager PL, Koran MEI, Petyuk VA, Robinson RA, Ruderfer DM, Cox NJ, Schneider JA (2020) APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer’s disease. Neurobiol Aging 87:18–25PubMed

43.

Zafar MI, Mills K, Ye X, Blakely B, Min J, Kong W, Zhang N, Gou L, Regmi A, Hu SQ (2018) Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis. Diabetol Metab Syndr 10(1):62PubMedPubMedCentral

44.

Staels W, Heremans Y, Heimberg H, De Leu N (2019) VEGF-A and blood vessels: a beta cell perspective. Diabetologia:1–8

45.

Azimi G, Ranjbaran F, Arsang-Jang S, Ghafouri-Fard S, Mazdeh M, Sayad A, Taheri M (2020) Upregulation of VEGF-A and correlation between VEGF-A and FLT-1 expressions in Iranian multiple sclerosis patients. Neurol Sci:1–7

46.

El Kadmiri N, Slassi I, El Moutawakil B, Nadifi S, Tadevosyan A, Hachem A, Soukri A (2014) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer’s disease. Pathol Biol 62(6):333–336PubMed

47.

Feng S, Shi T, Qiu J, Yang H, Wu Y, Zhou W, Wang W, Wu H (2017) Notch1 deficiency in postnatal neural progenitor cells in the dentate gyrus leads to emotional and cognitive impairment. FASEB J 31(10):4347–4358PubMed

48.

Cho S-J, Yun S-M, Jo C, Jeong J, Park MH, Han C, Koh YH (2019) Altered expression of Notch1 in Alzheimer’s disease. PLoS One 14(11):e0224941PubMedPubMedCentral

49.

Caputo V, Termine A, Strafella C, Giardina E, Cascella R (2020) Shared (epi) genomic background connecting neurodegenerative diseases and type 2 diabetes. World J Diabetes 11(5):155–164PubMedPubMedCentral

50.

Hu S, Cho E-H, Lee J-Y (2020) Histone deacetylase 9: its role in the pathogenesis of diabetes and other chronic diseases. Diabetes Metab J 44(2):234–244PubMedPubMedCentral

Titel: Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life
verfasst von: Zahra Salehi
Masoud Arabfard
Omid Sadatpour
Mina Ohadi
Publikationsdatum: 16.07.2020
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 3/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04594-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life

Abstract

Aim

Methods

Results

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Marchiafava–Bignami disease–like corpus callosum lesions due to moyamoya disease

Retinal nerve fiber layer changes in migraine: a systematic review and meta-analysis

Takotsubo cardiomyopathy: an obscure cause of emerging cardiovascular manifestations in the setting of Bickerstaff’s brainstem encephalitis

In the borderland of multifocal motor neuropathy and chronic inflammatory demyelinating polyradiculopathy

Vitamin D receptor gene polymorphism in patients with osteomalacic myopathy in Egypt

Clinical features associated with drooling in Parkinson’s disease

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie